![Tasigna Nilotinib 150 Mg Capsules at Rs 55545/box | Tasigna Capsules in Chandigarh | ID: 2853956372548 Tasigna Nilotinib 150 Mg Capsules at Rs 55545/box | Tasigna Capsules in Chandigarh | ID: 2853956372548](http://5.imimg.com/data5/SELLER/Default/2024/4/413207160/RB/CI/EF/219423426/nilotinib-capsules.jpg)
Tasigna Nilotinib 150 Mg Capsules at Rs 55545/box | Tasigna Capsules in Chandigarh | ID: 2853956372548
![Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial | Leukemia Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2016.5/MediaObjects/41375_2016_Article_BFleu20165_Fig1_HTML.jpg)
Long-term benefits and risks of frontline nilotinib vs imatinib for chronic myeloid leukemia in chronic phase: 5-year update of the randomized ENESTnd trial | Leukemia
![WO2021222739A1 - Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib - Google Patents WO2021222739A1 - Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib - Google Patents](https://patentimages.storage.googleapis.com/db/e2/98/8e5b93c94e3760/imgf000124_0001.png)
WO2021222739A1 - Orally disintegrating tablet comprising amorphous solid dispersion of nilotinib - Google Patents
![Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study | Leukemia Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study | Leukemia](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fleu.2015.270/MediaObjects/41375_2016_Article_BFleu2015270_Fig1_HTML.jpg)
Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study | Leukemia
![A Search for the Protonation Model with Thermodynamic Dissociation Constants and (Extra)-Thermodynamics of Nilotinib Hydrochloride (TASIGNA) | Journal of Solution Chemistry A Search for the Protonation Model with Thermodynamic Dissociation Constants and (Extra)-Thermodynamics of Nilotinib Hydrochloride (TASIGNA) | Journal of Solution Chemistry](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs10953-019-00882-2/MediaObjects/10953_2019_882_Fig2_HTML.png)
A Search for the Protonation Model with Thermodynamic Dissociation Constants and (Extra)-Thermodynamics of Nilotinib Hydrochloride (TASIGNA) | Journal of Solution Chemistry
![Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia - ScienceDirect Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0006497120731629-grabsf1.jpg)
Phase 2 study of nilotinib in pediatric patients with Philadelphia chromosome–positive chronic myeloid leukemia - ScienceDirect
![Pharmaceuticals | Free Full-Text | Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro Pharmaceuticals | Free Full-Text | Synthesis of Novel Nilotinib Analogues and Biological Evaluation of Their Antiplatelet Activity and Functionality towards Cancer Cell Proliferation In Vitro](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-17-00349/article_deploy/html/images/pharmaceuticals-17-00349-g001.png)